Inhibition of Growth of Chlamydia trachomatis by the Calcium Antagonist Verapamil

1 Department of Nephrology, Soroka Medial Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel 2 Institute of Pathology, Soroka Medial Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel 3 Virology Unit, S...

Full description

Saved in:
Bibliographic Details
Published inJournal of general microbiology Vol. 135; no. 6; pp. 1619 - 1623
Main Authors SHAINKIN-KESTENBAUM, RUTH, WINIKOFF, YEHUDIT, KOL, RINA, CHAIMOVITZ, CIDIO, SAROV, ISRAEL
Format Journal Article
LanguageEnglish
Published London Soc General Microbiol 01.06.1989
New York, NY Cambridge University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:1 Department of Nephrology, Soroka Medial Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel 2 Institute of Pathology, Soroka Medial Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel 3 Virology Unit, Soroka Medial Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel ABSTRACT Treatment of BGM (African Green Monkey kidney) cells with the calcium antagonist Verapamil resulted in a reduced yield of chlamydial infectious particles. The inhibitory effect was concentration-dependent, the maximal effect being achieved at 200 µM-Verapamil, which produced a 99·99% reduction of infectious particle yield. Electron microscopy showed that control Chlamydia trachomatis -infected BGM cells contained typical large inclusions in which most of the particles were elementary bodies, whereas Verapamil-treated infected cells contained small inclusions consisting predominantly of reticulate bodies. The findings indicate a possible therapeutic use of this calcium antagonist as an anti-chlamydial drug.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1287
1350-0872
1465-2080
DOI:10.1099/00221287-135-6-1619